Severe acute respiratory syndrome coronavirus-2 antibody prevalence in adults with HIV
We demonstrate a high rate of anti-S seropositivity following SARS-CoV-2 vaccination in people with HIV. Age over 60 was the only parameter found to be associated with a lower anti-S antibody titre. Our findings suggest that COVID-19 vaccine scheduling should target older persons with HIV in line with the general population.
Authors
- Tristan Barber (ORCID: https://orcid.org/0000-0003-1914-4891)
- Colette Smith (ORCID: https://orcid.org/0000-0003-2847-3355)
- Sanjay R. Bhagani (ORCID: https://orcid.org/0000-0003-2557-4337)
- Fiona Burns (ORCID: https://orcid.org/0000-0002-9105-2441)
- Sara Madge (ORCID: https://orcid.org/0000-0002-2381-2947)
- Mary Catherine Lucey (ORCID: https://orcid.org/0000-0002-3597-5989)
- Jennifer Hart
- Marc Lipman (ORCID: https://orcid.org/0000-0001-7501-4448)
- Dimitra Peppa (ORCID: https://orcid.org/0000-0002-9281-5471)
- Margaret Johnson (ORCID: https://orcid.org/0000-0003-1330-7100)
Institutions
- Royal Free London NHS Foundation Trust (GB)
- The Royal Free Hospital (GB)
- University College London (GB)
Publication Details
- Journal
- AIDS
- Published
- 2025-03-13
- DOI
- https://doi.org/10.1097/qad.0000000000004180
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 1.40